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Abstract
Background: Chronic fatiguing illnesses, including chronic fatigue syndrome (CFS), pose a diagnostic and
therapeutic challenge. Previous clinical reports addressed the utilization of health care provided to patients
with CFS by a variety of practitioners with other than allopathic training, but did not examine the spectrum
of complementary and alternative medicine (CAM) therapies used. This study was designed to measure
CAM therapy use by persons with fatiguing illnesses in the United States population.
Methods: During a random-digit dialing survey to estimate the prevalence of CFS-like illness in urban and
rural populations from different geographic regions of the United States, we queried the utilization of CAM
including manipulation or body-based therapies, alternative medical systems, mind-body, biologically-
based, and energy modalities.
Results: Four hundred forty fatigued and 444 non-fatigued persons from 2,728 households completed
screening. Fatigued subjects included 53 persons with prolonged fatigue, 338 with chronic fatigue, and 49
with CFS-like illness. Mind-body therapy (primarily personal prayer and prayer by others) was the most
frequently used CAM across all groups. Among women, there was a significant trend of increasing overall
CAM use across all subgroups (p-trend = 0.003). All categories of CAM use were associated with
significantly poorer physical health scores, and all but one (alternative medicine systems) were associated
with significantly poorer mental health scores. People with CFS-like illness were significantly more likely
to use body-based therapy (chiropractic and massage) than non-fatigued participants (OR = 2.52, CI =
1.32, 4.82). Use of body-based therapies increased significantly in a linear trend across subgroups of non-
fatigued, prolonged fatigued, chronic fatigued, and CFS-like subjects (p-trend = 0.002). People with chronic
fatigue were also significantly more likely to use body-based therapy (OR = 1.52, CI = 1.07, 2.16) and mind-
body (excluding prayer) therapy than non-fatigued participants (OR = 1.73, CI = 1.20 – 2.48).
Conclusion: Utilization of CAM was common in fatiguing illnesses, and was largely accounted for by the
presence of underlying conditions and poor physical and mental health. Compared to non-fatigued
persons, those with CFS-like illness or chronic fatigue were most likely to use body-based and mind-body
therapies. These observations have important implications for provider education programs and
development of intervention strategies for CFS.
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Background
Chronic fatiguing illnesses present diagnostic and man-
agement challenges for health care providers. Chronic
fatigue syndrome (CFS) is a complex illness characterized
by medically and psychiatrically unexplained disabling
fatigue that is not relieved by rest and is accompanied by
symptoms of prolonged postexertional malaise, unre-
freshing sleep, impaired concentration and short-term
memory, muscle or joint pain, headache, sore throat and
tender lymph nodes [1]. In population-based studies of
adults, the reported prevalence estimates for CFS appears
to be between 0.24% [2] and 0.42% [3], and prevalence
for CFS-like illness ranges from 0.25% [4] to 1.67% [5].
The illness is clinically challenging because, as yet, the eti-
ology, pathophysiology and risk factors for CFS remain
inchoate and treatment is targeted at treating symptoms
and amelioration of consequences rather than providing
a definitive cure.
Although not all persons suffering from CFS seek allo-
pathic care [6,7], standard regimens of therapy include
cognitive behavioral therapy, varying forms and regimens
of exercise, and enhancement of coping skills, while car-
egiver prescribed or self-administered medication use
remains common [8,9]. Recent increase in use of comple-
mentary and alternative medicine therapy (CAM) in vari-
ous forms by the population at large [10-13] as provided
by naturopaths, chiropractors, social workers, nutrition-
ists, and acupuncturists, and others, has also been
observed among patients with CFS [14-16]. Overall
reports of CAM therapy use in subjects with a range of
fatiguing illnesses have been based on clinical popula-
tions, have addressed the use of specific therapeutic
modalities, or have reviewed the subject. The field lacks a
systematic evaluation that addresses CAM use in fatiguing
illnesses in the population at large, correlates of use,
including demographic and geographic variables, pres-
ence of underlying illnesses, and standardized physical
and mental health scores.
We examined the use of CAM categories and conventional
medicine in a cross-sectional population survey of fatigu-
ing illnesses in the United States and evaluated variables
associated with their utilization Specifically we asked the
following questions: (i) Do CFS-like and otherwise
fatigued subjects use CAM and, if so, is it used more or less
frequently than non-fatigued persons; (ii)Which modali-
ties do they use; iii) What effects do demographic and geo-
graphic factors have on the association of CAM use and
fatigue classification; (iv) Do the presence of accompany-
ing/underlying illness and impaired health in general
affect the use of CAM; (v) What conclusions can we make
from the available data on CAM use by fatigued individu-
als that could be potentially useful to providers in their
management of fatigued persons?
Methods
This study adhered to human experimentation guidelines
of the U.S. Department of Health and Human Services
and the Helsinki Declaration. The CDC Human Subjects
committee approved study protocols. All participants
were volunteers who gave informed consent.
Sampling Strategy
Data were collected during a random-digit dialing survey
to estimate the prevalence of fatiguing illnesses in urban
and rural populations from different geographic regions
of the United States between July 2001 and January 2002
as detailed in Bierl et al.[5]. In brief, we used random digit
dialing telephone survey to screen 2,728 randomly
selected households. We conducted detailed telephone
interviews of 455 persons between 18 and 69 years of age
(76% participation), identified by the household inform-
ant (during the screening interview) as fatigued ≥ 1 month
and 444 (74% participation) randomly selected persons
identified as non-fatigued. Sampling included 8 geo-
graphic strata – Buffalo-Niagara Falls, New York (North-
east urban), Chicago, Illinois (Midwest urban), Baton
Rouge, Louisiana (South urban), Oakland, California
(West urban), Franklin County, Pennsylvania (Northeast
rural), Ripley County, Indiana (Midwest rural), Monroe
County, Georgia (South rural), and Chaves County, New
Mexico (West rural). In each selected household, we
screened an adult informant who enumerated individual
household members and reported on their age, sex, race,
and fatigue status. Informants were asked whether any
household members were currently suffering from severe
fatigue, extreme tiredness, or exhaustion that had lasted 1
month or longer.
Data Collection
We conducted standardized detailed telephone interviews
with household residents between 18 and 69 years of age
who the informant identified as fatigued ≥ 1 month, and
with a random sample of non-fatigued (NF) residents
identified in the screening interview. The detailed inter-
view [2,5] required approximately 30 minutes to com-
plete and included questions on fatigue (duration of less
than or greater than 6 months and whether it was relieved
or not by rest), presence or absence of 19 symptoms dur-
ing the preceding 4 weeks (8 specific for CFS and 11 asso-
ciated with general illness), and symptom duration (less
than or greater than 6 months). These data were used to
classify subjects into subgroups of fatigued and NF partic-
ipants. Information on demographics and history of pre-
existing medical and psychiatric diagnoses were also col-
lected and examined as covariates in our analyses. The
interview also included the 12-item Short Form Health
Survey (Quality-Metric, Inc., Lincoln, RI) that measures
health related quality of life and functional impairment
[17], which was also examined as a covariate. Finally, weBMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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obtained data on use of various CAM therapies in the past
12 months, and whether the subject discussed use of these
therapies with their doctor, by administering the ques-
tionnaire shown in Table 1.
CAM Modalities and Categories
Since this study was formulated in 1999, we used as an
operational definition the CAM modalities initially
addressed by Eisenberg et al., [10] as assigned to 5 catego-
ries by Berman and Straus [18] including: 1) manipulative
or body-based interventions including chiropractic and
massage therapies; 2) alternative medical systems, such as
homeopathy; 3) mind-body interventions including bio-
feedback, hypnosis, image/visual therapy, mindful exer-
cise, personal prayer, prayer by others, relaxation
techniques and self-help; 4) biologically-based therapies
including diet supplements, herbal supplements, and
vitamins; 5) energy therapies including acupuncture and
energy healing. In addition we asked whether subjects dis-
cussed use of CAM therapies with providers, whether use
was for treatment or prevention, and usefulness of the
treatment(s) (Table 1).
Classification of Study Participants
Individuals reporting fatigue lasting between one and 5-
months were classified as having prolonged fatigue (PF);
those with ≥ 6 months of fatigue were classified as having
chronic fatigue (CF); and persons without fatigue for one
month were considered as non-fatigued (NF). We classi-
fied chronically fatigued respondents as having a CFS-like
illness if their fatiguing illness met criteria of the 1994 CFS
research case definition [1]. In brief, criteria for CFS-like
illness included chronic fatigue that was not alleviated by
rest, and was accompanied by at least 4 of 8 symptoms
(unusual post-exertion fatigue, impaired memory/con-
centration, unrefreshing sleep, headache, muscle pain,
joint pain, sore throat, tender lymph nodes). The inter-
view did not assess whether fatigue substantially inter-
fered with work, educational, or personal activities, which
is characteristic of CFS, nor did this study include a phys-
ical and psychiatric evaluation to confirm conditions that
exclude classification as CFS. Fatigue categories were ana-
lyzed as discrete groups (NF, PF, CF and CFS-like), and
each subject was counted only in the most applicable
restrictive category.
Statistics
This study analyzed the use of the 5 CAM categories
(described above) by various groups of fatigued (CFS-like,
CF, and PF) and NF subjects and examined the effect of
various covariates on this relationship. For the purpose of
analysis, race was categorized as White, Black and Other,
geographic region was categorized as Northeast, South,
West, or Midwest and rural and urban areas were analyzed
separately. Education was categorized as <high school,
high school graduate, some college or post-high school
training, college graduate and post-graduate. Information
on categorical household income was collected and
treated as a dichotomous variable of ≤$40,000, >$40,000
based on the US median income. Physical and mental
health scores, as measured by the SF-12, were treated as
continuous measures. Other medical/psychiatric condi-
tions were treated as counts in the analysis.
All statistical analyses were conducted in SAS version 9.0
(SAS Institute Inc, Cary, NC). We compared categorical
variables between study groups by using either Chi-square
or Fisher's exact tests and compared continuous variables
Table 1: Study Questions Concerning Use of CAM Therapies.
Did you discuss use of these treatments with your doctor?
Do you use or have you used any of the following forms of therapy in the preceding 12 months?
Acupuncture
Biofeedback
Chiropractic techniques
Commercial diet supplements
Energy healing, such as magnets, crystals, and energy emitting machines
Herbal and botanical supplements, such as ginseng, garlic, ginkgo biloba, echinacea, St. John's wort, or saw palmetto
High dose vitamins (not a daily multivitamin, or a daily calcium or iron supplement)
Homeopathy
Hypnosis
Imagery/visualization
Massage
Mindful exercise, such as yoga or tai chi
Personal prayer
Spiritual healing or prayer by others
Relaxation techniques, such as meditation
Self-help group, such as a 12 step program or support group
Are you using these approaches to treat and/or prevent a disease? Other treatments?
Do you think these approaches were useful?BMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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between study groups by using either the T-test or the Wil-
coxon rank-sum test. Correlations between continuous
variables were computed using the Pearson Correlation
Coefficient. We used separate multinomial logistic regres-
sion models (PROC GENMOD) to compute odds ratios
(OR) as estimates of risk of CAM use among participants
with various categories of fatiguing illness compared to
the NF group. Dependent variables in these models
included the following CAM categories: body-based, alter-
native medicine systems, mind-body including prayer,
mind-body excluding prayer, biologically-based, and
energy. All regression models included adjustment for age
(continuous), sex, and count of other medical or psychi-
atric conditions. Additional covariates were included if
they had p-values < 0.05 (income, education, geographic
region). We further examined the effect of general physi-
cal and mental health on the adjusted ORs for the associ-
ations of fatigue case status and CAM categories by
including the SF12 scores for physical and mental health
in the regression models. We computed 95-percent confi-
dence intervals (95% CI) to measure the precision of the
ORs. We evaluated trend in ORs across a gradient of
fatiguing illness categories by using separate logistic
regression models for each CAM outcome and assigning
values of 1–4 to a categorical variable representing study
groups (1 = NF, 2 = PF, 3 = CF, 4 = CFS-like), adjusting for
covariates. Wald test was used to calculate p-values for
trend (p-trend). As is standard practice in regression mod-
els, subjects with missing values for any independent var-
iable in a regression model were excluded from that
specific analytic model.
Results
Subjects
Four hundred forty fatigued people and 444 non-fatigued
(NF) respondents completed the full interview. Eligibility
and refusal rates were similar for the two groups [5]. Fifty-
three of the fatigued subjects were classified as prolonged
fatigue (PF), 338 as chronic fatigue (CF), and 49 satisfied
symptom criteria for CFS-like illness. These groups were
similarly distributed by race, however they differed signif-
icantly by age and sex, with the PF group having a younger
mean age and the NF group having a smaller proportion
of women than other groups (p < .0001 for both). The NF
group also reported a higher income than the three fatigue
groups (p < 0.0001) (Table 2).
CAM Use
Overall, 77% of participants reported using some CAM
therapy in the 12-month period prior to the interview.
Use of any CAM modality (i.e. ever in the preceding 12
months) was reported more frequently among women
(56.8%) than men (44.2) (p = 0.0003), and increased sig-
nificantly with increasing level of education (p-trend <
Table 2: Distribution of Demographic Factors by Illness Group
Demographic Factor CFS-like n = 49 Chronic Fatigue 
n = 338
Prolonged Fatigue 
n = 53
Non-Fatigued 
n = 444
p-value
Age (mean ± SD) 42.5 ± 10.6 46 ± 12.2 38.5 ± 13.9 43.2 ± 13.5 p < 0.0001
Sex: n (%)
Male 14 (28.5) 101 (29.9) 13 (24.5) 200 (45.0) p < 0.0001
Female 35 (71.4) 237 (70.1) 40 (75.5) 244 (54.9)
Race: n (%)
White 44 (89.8) 294 (86.9) 43 (81.1) 369 (83.1) p = 0.75
Black 3 (6.1) 24 (7.1) 8 (15.1) 46 (10.4)
Other 2 (4.1) 20 (5.9) 2 (3.8) 29 (6.5)
Income* (median): n (%)
≤$40,000 21 (51.2) 176 (57.7) 33 (71.7) 158 (41.9) p < 0.0001
>$40,000 20 (48.8) 129 (42.3) 13 (28.3) 219 (58.1)
Education:** n, (%)
< High school graduate 8 (16.7) 51 (5.8) 11 (20.7) 49 (11.4) p = 0.19
High school graduate 17 (34.7) 140 (41.4) 19 (35.8) 150 (34.8)
Some college 13 (27.1) 77 (8.8) 15 (28.3) 105 (24.4)
College graduate 6 (12.2) 38 (11.2) 3 (5.7) 79 (18.3)
Post graduate 4 (8.2) 27 (7.9) 5 (9.4) 48 (11.1)
SD: standard deviation; *105 subjects were missing information on income;
**19 subjects were missing information on educationBMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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0.0001). Reported use of any CAM modality did not sig-
nificantly vary by age, race, income or geographic regions
(Table 3). Use of any CAM modality was more common
(81.6%) among the combined groups of fatigued subjects
than NF subjects (72.5%) (p=.0006). There were no strik-
ing differences in the proportion of participants who
reported any CAM use between the PF, CF, and CFS like
groups (79.3%, 82.3%, and 79.6%, respectively), but the
mean number of CAM modalities used by each study
group increased across subgroups of PF – CF – CFS-like.
This trend was observed for women and men, but was sta-
tistically significant only among women (p = 0.03, p =
0.06 respectively).
The frequency of use of specific CAM therapies by study
group is shown in Table 4. Except for each therapy in the
biologically-based category, there was significant overall
variation in the frequency of use of at least one of the spe-
cific CAM therapies within each of the remaining CAM
categories (body-based, alternative medicine systems,
mind-body, and energy) by illness group. In addition,
within each of these CAM categories there was a signifi-
cant trend of decreasing frequency of reported use across
illness categories of CFS-like -CF-PF-NF for at least one
CAM therapy.
Underlying Medical or Psychiatric Conditions
Overall, a significantly higher proportion of the combined
group of fatigued participants (65.2%) reported having
various medical or psychiatric conditions than the non-
fatigued participants (38.5%) (p < 0.0001). None of these
conditions were exclusionary according to the definition
of CFS (1). The most commonly reported, but not veri-
fied, co-morbid diagnoses in the study population were:
hypertension (13%), diabetes mellitus of unknown type
(10%), thyroid disease (8%), asthma (8%), depression
Table 3: Distribution of Demographic Factors by Overall Use of Complementary and Alternative Medicine (CAM), excluding use of 
Prayer
Demographic FactorC A M  U s e p - v a l u e
No Yes
Age (years) p = 0.20
Mean ± st. deviation 43.9 ± 13.4 44.0 ± 12.7
Sex: n, (%) p = 0 .0003
Males 183 (55.7) 145 (44.2)
Females 240 (43.2) 316 (56.8)
Race: n, (%) p = 0.36
White 356 (47.8) 391 (52.1)
Black 43 (53.1) 38 (46.9)
Other 21 (40.4) 31 (56.6)
Income: n (%) p = 0.45
≤$40,000 42 (47.2) 47 (52.8)
>$40,000 163 (42.8) 218 (57.2)
Education: n (%) p = 0.0002
< High School 65 (54.6) 54 (45.4) p-trend < 0.0001
High School 176 (53.9) 150 (46.0)
Some College 93 (44.2) 117 (55.7)
College graduate 48 (38.1) 78 (61.9)
Post-graduate 26 (30.9) 58 (69.0)
Geographic Region: n (%) P = 0.85
Northeast 70 (25.1) 209 (74.9)
Midwest 40 (22.9) 135 (77.1)
South 56 (22.0) 198 (77.9)
West 40 (22.7) 136 (77.3)
Rural/Urban: n (%) P = 0.39
Urban 91 (24.7) 277 (75.3)
Rural 115 (22.3) 401 (77.7)BMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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(7%), fibromyalgia (6%), hyperlipidemia (4%), cardio-
vascular disease (4%) and identifiable sleep disorders
such as apnea and narcolepsy (<2%).
We examined the association of any CAM use with the
presence of a medical or psychiatric condition. Among the
NF and PF groups, similar proportions of those who did
and did not report any CAM use had a medical/psychiatric
condition (p = 0.19 and p = 0.68, respectively). However,
among the CF group and CFS-like group, significantly
higher proportions of those who reported any CAM ther-
apy use had a medical/psychiatric condition, compared to
those who did not use any CAM (p = 0.004, p = 0.0002,
respectively). The mean number of medical/psychiatric
conditions increased steadily across study groups, ranging
from an average of 0.65 among the NF group to 1.8
among the CFS-like group (p < .0001).
We also explored whether use of CAM was associated with
physical and mental health status, as measured by the SF-
12. Non-fatigued subjects had scores comparable to pub-
lished norms [17]. Since fatiguing illnesses can be defined
in part by questions used in the Medical Outcomes Survey
series [19], it is not surprising that the combined group of
all fatigued subjects had significantly lower scores in both
physical and mental health status compared to the NF
group (p < .0001 for both). Interestingly, persons who
reported using any of the 5 CAM categories had signifi-
cantly poorer physical health scores (i.e. lower median SF-
12 scores) than persons who did not report using CAM
therapies (Table 5). In addition, users of all but the alter-
native medicine system, homeopathy, had significantly
poorer mental health scores than persons who did not use
these CAM categories or conventional medicine.
Discussion of CAM Use with Providers
Overall, 37.5% of all respondents said that they discussed
their CAM therapy use with their physician, but this prac-
tice increased across subgroups, ranging from a frequency
of 26.1% among the NF subgroup to 57.6% among the
CFS-like group (p-trend = 0.0001). Individuals previously
diagnosed with CFS reported more CAM therapy use than
other persons with fatigue who were not diagnosed with
CFS.
Model of Association of CAM Use with Fatiguing Illnesses
Odds ratios for use of body-based therapy increased in a
significant trend across fatigue categories of PF, CF and
Table 4: Frequency of Utilization of Complementary and Alternative Medicine Modalities According to Illness Classification
CAM categories and specific 
modalities
CFS-like
 (n = 48)
Chronic Fatigue
 (n = 327)
Prolonged Fatigue
 (n = 53)
Non-fatigued
 (n = 435)
Overall p-Value p-Trend
n (%) n (%) n (%) n (%) n (%)
Body-based
Chiropractic 12 (25.5) 57 (17.0) 10 (18.9) 39 (9.0) .0004 .0001
Massage 17 (36.2) 71 (21.2) 1 (22.6) 65 (14.9) .002 .001
Alternative Medicine System
Homeopathy 7 (15.2) 30 (9.1) 1 (1.9) 26 (6.0) .03 .02
Mind-body
Biofeedback 3 (6.4) 8 (2.4) 1 (1.9) 6 (1.4) .12 .06
Hypnosis 0 (0) 4 (1.2) 0 (0) 0 (0) .11 --
Image/visual 7 (14.9) 39 (11.8) 9 (17.0) 34 (7.9) .07 .04
Mindful exercise 4 (8.5) 27 (8.0) 5 (9.4) 23 (5.3) .28 .11
Personal prayer 35 (74.5) 226 (67.5) 36 (67.9) 252 (58.1) .01 .002
Prayer by others 23 (48.9) 114 (34.0) 12 (22.6) 92 (21.1) <.0001 <.0001
Relaxation 11 (23.4) 90 (26.9) 10 (19.2) 60 (13.8) .0001 <.0001
Self-Help 4 (8.5) 25 (7.5) 0 (0) 14 (3.2) .01 .004
Biologically-based
Diet supplements 8 (17.0) 47 (14.0) 2 (3.8) 50 (11.5) .12 .17
Herbal supplements 13 (27.7) 75 (22.4) 10 (18.9) 80 (18.4) .30 .07
Vitamins 5 (10.6) 28 (8.5) 5 (9.4) 28 (6.4) .56 .27
Energy
Acupuncture 1 (2.1) 8 (2.4) 2 (3.8) 5 (1.1) .25 .21
Energy healing 4 (8.5) 24 (7.2) 2 (3.8) 16 (3.7) .10 .02
Due to missing values, percentages cannot be computed based on total subjectsBMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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CFS-like subjects (p-trend = .0003) (Table 6). Notably, the
CFS-like group had a greater than 3-fold increased likeli-
hood of using body-based therapy (OR = 3.82, CI = 1.94,
7.51) than the NF group, after adjusting for age and sex.
However, after further adjustment for number of other
diagnosed medical and psychiatric conditions reported by
participants, the association of body-based therapy with
the CFS-like group was diminished, but remained statisti-
cally significant (OR = 2.52, CI = 1.32, 4.82), as did the
trend across study groups (p = 0.002). Body-based therapy
was also significantly more likely to be used by the CF
group compared to the NF group (OR = 1.52, CI = 1.07,
2.16). Use of body-based therapy was also independently
and significantly associated with female sex, high income
and higher number of other diagnoses (p = 0.002, p =
0.003, p = 0.03, respectively).
The CFS-like group was also 2.9-times more likely to
report using an alternative medical system (represented by
homeopathy) compared to the NF group after adjusting
for age, sex, education and census region (OR = 2.91 CI =
1.14, 7.40); there was also a significant trend of decreasing
ORs associated with homeopathy use across study groups
(p-trend < .0001) (Table 6). After further adjusting for
number of other diagnoses, the OR associated with home-
opathy use among persons with CFS-like illness was atten-
uated and no longer statistically significant (OR = 2.55, CI
= 0.96, 6.71). The trend associated with homeopathy use
by the fatigue subgroups was also no longer statistically
significant (p = 0.07). However, use of homeopathy was
independently and significantly associated with female
sex, higher level of education and geographic area, with
use reported more frequently in the West region of the
U.S. (p = 0.007, p < .0001 p = 0.03, respectively).
Mind-body CAM use was not reported significantly more
often by any of the fatigue groups compared to the NF
group (Table 6). However, personal prayer and prayer by
others are considered mind-body therapies and are com-
monly practiced by all study groups. After removing per-
sonal prayer and prayer by others from the mind-body
category (which left image/visual therapy, mindful exer-
cise, relaxation techniques), use of any of these remaining
mind-body therapies was 73% more likely among the CF
Table 5: Distribution of Median Scores for the SF-12 Physical and Mental Health Subscales, by Category of CAM Use
CAM Category/Conventional Use Physical Health Median Score (range) Mental Health Median Score (range)
Body-based
Yes (n = 228) 44.8 (14.1 – 62.4) 46.3 (17.8 – 66.4)
No (n = 623) 50.4 (12.1 – 64.9) 50.6 (14.2 – 67.6)
(p < 0.0001) (p = 0.01)
Alternative Medicine
Yes (n = 64) 44.9 (18.8 – 60.1) 44.1 (19.1 – 64.7)
No (n = 787) 49.6 (12.1 – 64.9) 49.7 (14.2 – 67.6)
(p = 0.04) (p = 0.14)
Mind-body (excluding prayer)
Yes (n = 219) 44.6 (12.1 – 64.9) 44.6 (17.8 – 66.4)
No (n = 632) 50.8 (12.7 – 64.6) 50.6 (14.2 – 67.6)
(p < 0.0001) (p < 0.0001)
Mind-body (including prayer)
Yes (n = 579) 48.1 (12.1 – 64.9) 47.3 (14.6 – 66.4)
No (n = 272) 51.4 (15.8 – 61.4) 52.5 (14.2 – 67.6)
(p = 0.001) (p < 0.0001)
Biologically-based
Yes (n = 220) 48.3 (12.1 – 64.9) 44.6 (14.6 – 66.4)
No (n = 631) 49.6 (12.7 – 64.6) 50.3 (14.2 – 67.6)
(p = 0.36) (p < 0.0001)
Energy
Yes (n = 59) 41.9 (18.0 – 60.6) 43.2 (19.1 – 63.4)
No (n = 792) 49.7 (12.1 – 64.9) 49.9 (14.2 – 67.6)
(p = 0.003) (p = 0.001)
p-values are based on the Wilcoxon test
SF-12 norms by age group: 18–44 years = Physical 52.5, Mental 48.4; 45–55 years = Physical 50.2, Mental 50.8BMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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group compared to the NF group (OR = 1.73, CI = 1.20–
2.48), and there was a significant trend of decreasing like-
lihood of use across study groups of CFS-like – CF-PF – NF
(p-trend = .006). In addition, use of such mind-body ther-
apies was independently and significantly associated with
females sex, higher education and higher number of other
diagnoses (p = 0.003, p < 0.0001, p = 0.001, respectively).
None of the fatigue subgroups were significantly more
likely to use biologically based therapies than the NF
group; however, use of biologically based therapies was
significantly associated with higher education and a
higher number of other diagnoses (p < 0.0001, p = 0.002).
We further examined whether the associations of body-
based CAM and mind-body (excluding prayer) CAM use
with CFS-like illness and chronic fatigue, respectively,
could be accounted for by physical or mental health. SF-
12 scores for physical health and mental health were sig-
nificantly but weakly correlated (r = 0.15, p < 0.0001),
allowing for their simultaneous addition to the fully
adjusted models predicting use of these CAM categories.
Physical health remained significantly and independently
associated with use of body-based CAM (p = 0.002) after
consideration of illness group and other covariates. Men-
tal health remained significantly and independently asso-
ciated with use of the mind-body CAM (excluding prayer)
(p = 0.003). However, after accounting for the effects of
physical and mental health scores, the association
between CFS-like illness and body-based CAM use was
attenuated and no longer statistically significant (OR =
2.05, CI = 0.96 – 4.39). The association of CF illness and
mind-body (excluding prayer) CAM was no longer
detected (OR = 0.91, CI = 0.59 – 1.42).
Discussion
Our study addressed the use of complementary and alter-
native medicine (CAM) therapies identified in the 1990's
by persons with fatiguing illnesses and non-fatigued per-
sons. As defined here, 77.0% of subjects reported CAM
use between July 2001 and January 2002, a greater pro-
portion than that previously reported at the national level,
where in general it ranged from 36% in 1990, to 46% in
1997, and 62% in 2002 [10-13]. The obvious difference
between the current report and previous observations is
the inclusion of subjects with fatiguing illnesses in this
report, 81.6% of whom reported CAM therapy use versus
40% use by those with specific illnesses in the 2002 study
(13). However the non-fatigued subjects in our study
reported an overall 72.5% prevalence of CAM therapy use.
The less obvious difference in prevalence observed here is
related to the exclusion of analyses of personal prayer in
earlier published reports. Personal prayer was used more
than any other CAM in our study; 63.1% of our study sub-
jects reported its use compared to 43% in the general pop-
ulation in 2002. Our results are reminiscent of data from
1999 National Health Interview Survey [20], which found
that prayer and herbs were the most common CAM thera-
pies used, with the greatest use among those with self-
described poor health.
Compared to the non-fatigued group, persons classified as
having CFS-like illness and those classified as having
chronic fatigue were significantly more likely to use only
the body-based CAM therapy category, which includes
chiropractic and massage therapies. We also found that
compared to the NF group, frequency of use of body-
based therapy by subjects with fatigue increased across
groups of PF, CF and CFS-like in a linear trend.
After excluding use of personal prayer and prayer by oth-
ers, use of other components of the mind/body category
was reported significantly more often by the chronic
fatigue group compared to the non-fatigued group. How-
ever, the ORs associating use of these and other CAM cat-
egories were substantially attenuated when we adjusted
for the number of other, non-exclusionary medical/psy-
chiatric diagnoses. Further adjustment for physical and
mental health, as measured by scores on the SF-12, further
diminished these associations and resulted in their non-
significance. Taken together, these data suggest that both
Table 6: Adjusted Odds Ratios (OR) and 95% Confidence Intervals (CI) for Associations of Fatigue Groups with Use of Complementary 
and Alternative Medicine Categories
CFS-like Chronic Fatigue Prolonged Fatigue Non-fatigued p-trend
CAM use OR 95% CI OR 95% CI OR 95% CI OR
Body-Based† 2.52 (1.32–4.82) 1.52 (1.07–2.16) 1.67 (0.88–3.17) 1.0 0.002
Alternative Medicine^+ 2.55 (0.97–6.71) 1.43 (0.79–2.59) 0.29 (0.04–2.22) 1.0 0.07
Mind-body (includes Prayer)^ 1.33 (0.63–2.83) 1.17 (0.83–1.66) 1.39 (0.70–2.73) 1.0 0.28
Mind-body (excludes Prayer)^ 1.47 (0.73–2.97) 1.73 (1.20–2.48) 1.65 (0.84–3.22) 1.0 0.006
Biologically-based^ 1.48 (0.77–2.87) 1.19 (0.84–1.68) 0.92 (0.46–1.81) 1.0 0.19
Energy 1.86 (0.65–5.38) 1.58 (0.86–2.91) 1.54 (0.50–4.74) 1.0 0.09
All models include adjustment for age (continuous) and sex and count of other diagnoses; † includes adjustment for income; ^ includes adjustment 
for education; +includes adjustment for geographic areaBMC Complementary and Alternative Medicine 2007, 7:12 http://www.biomedcentral.com/1472-6882/7/12
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the presence of "other diagnoses" and poorer physical and
mental health account for some of the use of body-based
and mind-body CAM therapies by persons with CFS-like
illness and CFS.
Pearson et al. [21] identified insomnia, hypertension,
congestive heart failure, anxiety or depression, and obes-
ity, as entities leading to the use of CAM therapies. In prin-
ciple, our data support this conclusion, since
hypertension, depression, and conditions known to be
risk factors for congestive heart failure (hyperlipidemia,
diabetes mellitus) were among the common underlying
medical conditions in our study. Insomnia, in the absence
of diagnosable sleep disorders, and as defined by Pearson
et al., [21], however, is included in the CFS construct and
could not be considered as a separate underlying condi-
tion. In practice we did not specifically address the ques-
tion of whether CAM therapy was used for the fatiguing
illnesses that were identified or for an underlying disease.
In the general population, CAM therapies were used as
adjuncts to standard care, health promotion, or disease
prevention [10]. Although we asked participants whether
they used CAM for treatment or prevention of illness, we
question the validity of this measure based on the ambig-
uous response categories and did not include it in our
analysis. However, a higher proportion of subjects in the
CFS-like (57.5%) and CF (47.9%) groups discussed their
use of CAM with their primary providers than the non-
fatigued CAM users (26.1%), suggesting that persons with
fatiguing illnesses use both allopathic and alternative
medical care. Further analysis of subject's rationale for use
of CAM and the relationship to satisfaction with allo-
pathic care is necessary in order to determine if CAM ther-
apies are used in deference to standard care [22].
Interpretation of our results must take into consideration
the limitations of this study. We classified subjects based
on telephone interviews with the inherent problems of
under-representation of low income, and transient popu-
lations, and did not conduct in-person interviews, physi-
cal examinations or laboratory tests to rule out other
conditions associated with fatigue. It is known that
approximately 20% of those diagnosed with CFS or CFS-
like illness have other conditions that are exclusionary for
the diagnosis of CFS [3], so it is likely that our CFS-like
group includes persons who would have been excluded
had we conducted further screening tests. Thus our results
cannot be generalized to CFS, but rather, would be useful
to physicians and other health care providers whose prac-
tices include approximately 25% of patients with unex-
plained fatiguing illnesses. In addition, our analysis
involved comparisons of multiple CAM categories
between 3 fatigued groups and a NF group, increasing the
probability of finding an association by chance. However,
after adjusting for covariates that included physical and
mental health, as well as other medical and psychiatric
conditions, none of the associations of increased CAM use
by the CFS-like or CF groups remained significant, making
adjustment for multiple comparisons unnecessary.
On a practical note, physicians see and classify these
patients and must know about their use of CAM in order
to plan or modify their evaluation, diagnosis, and treat-
ment strategy. Understanding the patients' rationale for
CAM therapy and their perception of its efficacy may pro-
vide information on whether symptoms or the illness dic-
tate intervention and on positive or negative
consequences of CAM therapy [23,24]. Further informa-
tion on the use of prayer and its efficacy in treating ill-
nesses, as well as the place of prayer in studies of CAM
therapy are needed. This issue should be examined within
the context of general health status and cultural and reli-
gious practices [25].
Conclusion
CAM use in fatiguing illness is more prevalent than it is in
non-fatigued persons. Body-based therapies (chiropractic
and massage therapy) and mind-body (excluding prayer)
therapies were significantly more likely to be used by per-
sons with chronic fatigue or CFS-like illnesses, compared
to non-fatigued controls. However, poorer physical and
mental health and the presence of other physical and psy-
chiatric conditions, appear to account for greater use of
these CAM therapies by persons with chronic fatigue and
CFS-like illness.
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